***** solbec ***** , page-2

cmon mate,its fairly common for a stock to retrace after some news.this announcement of human trials is major bannana.i am always sceptical of any biotech in early stages.but you cannot denie the results acheived from the SPECAIL ACESS SCHEUME.they have recieved absolutley outstanding results on people that have been told to go home and die.the fact is now that they can get the drug to people at a much earlier stage of diagnosis.they already know how patient freindly the drug is RE:minimal side effects.they will go through stage 1 with out a problem.after this small retrace bottoms out i think SBP will have a steady climb.